USPTO serial 78213862
ADENOMED
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBOIS, SUSAN L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADENOMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NC Amstelveen, NL
NC Amstelveen, NL
Luchthaven Schipol, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Barry L. Kelmachter
BARRY L KELMACHTER BACHMAN & LAPOINTE PC900 CHAPEL ST STE 1201NEW HAVEN, CT 06510-2889UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating cardiovascular diseases namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation, venous disorders namely deep venous thrombosis, cerebral diseases, namely, stroke, neurodegenerative pathologies, Alzheimer's disease, Parkinson disease, sleep pathologies, depression, anxiousness, psychotic disorders, epilepsy, migraine headaches, inflammatory diseases, namely osteoarthritis, rheumatoid arthritis, alkylosing spondylitis, tedonitis, acute gout, inflammatory bowel diseases, prostates, dysmenorrhoea, post-traumatic oedema, fever, cancer, colorectal cancer, ovarian cancer, breast carcinoma, leukemia, prostate cancer, neuroblastoma, apoptosis processes, cancer cachexia syndrome, inhibiting tumor cell growth, chemotherapy efficacy enhancers, immune diseases induced by virus, namely herpes, herpes, zoster, and Aids, diabetes, cholesterol and lipid disorders, eye disease, retina ischemic, retina degeneration, glaucoma, and dry eye, sexual dysfunction, angiogenesis, inner ear disease, neuropathic pain, pain during anaesthesia, pulmonary diseases, cystic fibrosis, pulmonary hypertension, exocrine gland disease; antiseptic, dietary food supplements, animal feed additive for use as a nutritional supplement; and dressings for wounds, burns and surgical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ilgen, Hans Michael
- Other trademarks owned by Ilgen, Hans Michael
- Other trademarks owned by ADENOMED B.V.
- Other trademarks in Class 005
- Similar marks named ADENOMED
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 10, 2007 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 7, 2007 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 23, 2007 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 18, 2007 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 18, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 23, 2006 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 2, 2006 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 19, 2006 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 19, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2006 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 5, 2006 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 5, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2005 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 6, 2005 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 6, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 5, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 5, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 20, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 27, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 7, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 20, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2004 | PAPER RECEIVED | — | |
| Aug 6, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2003 | DOCK | ASSIGNED TO EXAMINER | — |